These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2499633)

  • 1. Recruitment and activation of tumor-specific immune T cells in situ. CD8+ cells predominate the secondary response in sponge matrices and exert both delayed-type hypersensitivity-like and cytotoxic T lymphocyte activity.
    Zangemeister-Wittke U; Kyewski B; Schirrmacher V
    J Immunol; 1989 Jul; 143(1):379-85. PubMed ID: 2499633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of interleukin 2 and interleukin 4 by immune CD4-CD8+ and their role in the generation of antigen-specific cytotoxic T cells.
    Horvat B; Loukides JA; Anandan L; Brewer E; Flood PM
    Eur J Immunol; 1991 Aug; 21(8):1863-71. PubMed ID: 1907920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells.
    McCarthy SA; Kaldjian E; Singer A
    J Immunol; 1989 Oct; 143(7):2112-9. PubMed ID: 2528588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment and activation of tumor-specific immune T cells in situ: functional studies using a sponge matrix model.
    Zangemeister U; Thiede K; Schirrmacher V
    Int J Cancer; 1989 Feb; 43(2):310-6. PubMed ID: 2783923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
    Cron RQ; Gajewski TF; Sharrow SO; Fitch FW; Matis LA; Bluestone JA
    J Immunol; 1989 Jun; 142(11):3754-62. PubMed ID: 2523934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus.
    Mizuochi T; Hügin AW; Morse HC; Singer A; Buller RM
    J Immunol; 1989 Jan; 142(1):270-3. PubMed ID: 2521235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell tumor cure by T cell receptor-mediated activation requires the development of CD8-dependent host immunity.
    Bridges SH; Longo DL
    J Immunol; 1990 Mar; 144(5):2010-7. PubMed ID: 2155271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The DTH-initiating Thy-1+ cell is double-negative (CD4-, CD8-) and CD3-, and expresses IL-3 receptors, but no IL-2 receptors.
    Herzog WR; Ferreri NR; Ptak W; Askenase PW
    J Immunol; 1989 Nov; 143(10):3125-33. PubMed ID: 2478617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
    Ellenhorn JD; Schreiber H; Bluestone JA
    J Immunol; 1990 Apr; 144(7):2840-6. PubMed ID: 1969454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help.
    Leist TP; Kohler M; Eppler M; Zinkernagel RM
    J Immunol; 1989 Jul; 143(2):628-32. PubMed ID: 2544648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
    Li Y; McGowan P; Hellström I; Hellström KE; Chen L
    J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.
    Nagler-Anderson C; Verret CR; Firmenich AA; Berne M; Eisen HN
    J Immunol; 1988 Nov; 141(10):3299-305. PubMed ID: 2972770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.
    Gabrilovich DI; Ciernik IF; Carbone DP
    Cell Immunol; 1996 May; 170(1):101-10. PubMed ID: 8665590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of murine gamma delta T cells cytotoxic for xenogeneic rat cells.
    Okumura C; Suto R; Furukawa K; Ahmed SS; Furukawa K; Nakayama E; Fujii T; Shiku H
    J Immunol; 1995 Feb; 154(3):1114-23. PubMed ID: 7822788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.